| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 |
| Sales | 12,250 | 11,050 | 7,230 | 1,890 | 900 |
| Sales Growth | +10.86% | +52.84% | +282.54% | +110.00% | -4.26% |
| Net Income | 160 | -14,920 | -24,750 | -8,570 | -10,880 |
| Net Income Growth | +101.07% | +39.72% | -188.80% | +21.23% | -40.03% |
Guardion Health Sciences Inc (GHSI)
3.2200 -0.0700 (-2.13%) 10/31/24 [OTC US]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Wed, Oct 30th, 2024
Guardion Health Sciences Inc. is an ocular health sciences company. It develops, formulates and distributes condition-specific medical foods supported by evidence-based protocols, with an initial medical food product which addresses a depleted macular protective pigment. The company also developed a proprietary medical device, the MapcatSF(R), which accurately measures the macular pigment density. Guardion Health Sciences Inc. is based in San Diego, United States.
Fiscal Year End Date: 12/31